Yale Study Identifies Which Anti-Aging Approaches Measurably Lower Biological Age
A review of clinical trial data by Yale researchers shows that prescription drugs and lifestyle changes can alter biological age markers, while over-the-counter supplements show little effect.
🧠AI AnalysisPhoto: ScienceDaily Cancer
Key points
- Yale researchers examined data from 51 clinical studies using blood-based epigenetic clocks to evaluate anti-aging interventions.
- Prescription medications and lifestyle interventions showed measurable reductions in biological age, whereas over-the-counter supplements showed minimal impact.
- Scientists caution that improvements in biological age markers do not guarantee prevention of age-related diseases or an increased lifespan.
A broad review of clinical trial data led by scientists at the Yale School of Medicine indicates that specific prescription medications and targeted lifestyle modifications can measurably lower biological age. In contrast, popular over-the-counter dietary supplements demonstrated little evidence of producing similar biological changes. The findings were published in the journal Nature Medicine.
To evaluate which anti-aging strategies produce verifiable biological impacts, the research team analyzed outcomes across 51 clinical trials. Lead author Raghav Sehgal and senior author Albert Higgins-Chen examined more than 110 DNA methylation biomarkers and 16 epigenetic clocks—algorithms that calculate biological age by measuring chemical patterns attached to DNA. Their comparison revealed that prescription therapies and lifestyle interventions consistently influenced these chemical markers, whereas over-the-counter supplements generally failed to show significant shifts.
What to know: Although the study highlights measurable responses in biological age markers, the authors emphasize that a reduction in biological age does not automatically translate to a longer lifespan or protection against age-related conditions like cancer, diabetes, or dementia. Epigenetic clocks are sophisticated tools for tracking biological changes, but further long-term research is needed to determine their exact relationship to overall health outcomes. Readers should consult a healthcare provider before starting any new medication or major health regimen.
Source ScienceDaily Cancer — sciencedaily.com/releases/2026/11/261112230452.htm ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.